Posts by Robert S. Bader, M.D., Dermatologist
ELECTRONIC MEDICAL RECORDS ALLOW PATIENTS TO SEE THEIR MEDICAL RECORDS ONLINE
Most current electronic medical record systems now allow patients to access parts of their medical records online. Patient’s can now view laboratory results, pathology reports, visit notes, and more by logging into an “online patient portal”. This is in response to new Federal guidelines requiring such patient access for providers wishing to participate in the Federal EHR…
Read MoreTANNING BEDS MAY BE MORE DANGEROUS THAN YOU THINK
A British study has shown that the risk of skin cancer from tanning beds is more than double that of spending the same time in midday Mediterranean sun. The study found that the average strength of the tanning beds was approaching more than twice the recommended limit of ultraviolet radiation.
Read MoreCAN YOUR PHONE REALLY DIAGNOSE MELANOMA? NOT SO FAST!
According to an study published in JAMA Dermatology which evaluated 4 smartphone applications that analyze photographs to identify malignant melanoma, the apps were able to make the diagnosis of malignant melanoma between 6.8% to 98.1% of the time. The app that was found to be most effective sends the photographs to a Dermatologist for evaluation. What is important…
Read MoreCHILDREN USE MORE SUNSCREEN WHEN DISPENSED FROM A PUMP
A study published in the Archives of Dermatology found that children use the most sunscreen when dispensed from a pump, when compared with squeeze bottles and roll-on dispensers. Despite this finding, kids used half of the recommended amount even with the pump-dispenser.
Read MoreSENTINEL LYMPH NODE BIOPSY (SLNB) MAY NOT BE INDICATED FOR MOST MELANOMAS <1MM THICK
New guideline issued jointly by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SOS), and published online July 9 in the Journal of Clinical Oncology do not recommend SLNB for tumors that are less than 1mm thick, unless there is ulceration present or rapidly diving cancer cells present. The study reported that there is insufficient…
Read MoreDYSPORT REBATE IS BACK: $50 REBATE OFF ANY DYSPORT TREATMENT UNTIL MARCH 31, 2012
Patients treated betwen Feb 1 and March 31, 2012 are eligible for a $50 rebate from Medicis. Please visit www.DysportUSA.com for more details.
Read MoreSINGLE TREATMENT TATTOO REMOVAL: IT IS NOW POSSIBLE TO REMOVE TATTOOS IN A SINGLE TREATMENT SESSION
Tattoo removal is costly and requires 4-6 laser treatment sessions. A recent study has shown that if one has 4 Alexandrite laser treatments performed 20 minutes apart in a single session, 61% can expect complete clearing of their black, green, and blue tattoos with no increased risk for scarring. Although relatively new, this treatment protocol…
Read MoreRESTYLANE AND PERLANE REBATE IS BACK: OFFER EXPIRES MARCH 31, 2012
Patients will receive a rebate of: $40 per cc of Restylane (minimum of 2-cc must be used in a single session to be eligible and there is a maximum of $360) $50 per cc of Perlane (no minimum and there is a maximum of $300) visit www.RestylaneUSA.com for details.
Read MoreCHILDREN USE MORE SUNSCREEN WHEN DISPENSED FROM A PUMP
A study published in the Archives of Dermatology found that children use the most sunscreen when dispensed from a pump, when compared with squeeze bottles and roll-on dispensers. Despite this finding, kids used half of the recommended amount even with the pump-dispenser.
Read MoreMELANOMA DRUG VEMURAFENIB MAY INCREASE RISK OF SQUAMOUS CELL CARCINOMA
According to a study published in the New England Journal of Medicine, Vemurafenib (Zelboraf) speeds the growth of squamous cell carcinoma. HealthDay explained that “roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.”
Read More